KATRINA AMSLER: Open Payments
NPI 1619351855 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 19 payments from 9 companies in 2025. Trend: 2023 $869 · 2024 $891 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $154 |
| PFIZER INC. | 4 | $100 |
| SCPHARMACEUTICALS INC. | 4 | $77 |
| Impulse Dynamics (USA) Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Philips North America LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $6 |
Products named: Ozempic, VYNDAQEL, FUROSCIX, Optimizer, UPTRAVI, Wegovy, Ambulatory Monitoring & Diagnostics Undivided, FARXIGA.
Industry payments across VA — which companies pay providers there.
